Domestic SUPPLY Act of 2025

This bill focuses on making more personal protective equipment (PPE) in the United States and keeping steady supplies ready for health emergencies. It tells the Department of Health and Human Services to partner with U.S. companies so factories and supply lines can quickly make PPE when needed. The PPE must meet CDC and OSHA safety rules, have FDA clearance when required, and use fair-market pricing. The agency must set up the purchasing process within one year, and the deals are meant to guarantee both supply and manufacturing capacity during emergencies. To take part, companies must be based in the continental U.S., be majority U.S.-owned, have secure supply chains, and move their federal-order production to 50% U.S.-made in 2026, 75% in 2027, and 100% in 2028.

The bill also says the federal government, and state or local governments using federal funds, can only buy infection-control clothing and equipment that is made in the U.S., with narrow exceptions that must be explained in writing. In addition, HHS must report within a year on how federal PPE rules changed since COVID-19 began and how those changes affected frontline doctors and other medical workers in 2020 and 2021.

• Who is affected: U.S. PPE makers; federal, state, and local agencies that buy PPE with federal funds; health care workers and patients.
• What changes: New purchasing partnerships to guarantee PPE supply; buy-American rules for infection-control gear; PPE must meet safety standards and fair pricing; qualified products must have FDA clearance where required.
• When: Purchasing process finalized within 1 year of enactment; U.S.-made targets for federal orders are 50% in 2026, 75% in 2027, and 100% in 2028; buy-American rule starts on the date the bill becomes law; the report is due within 1 year.